{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T11:53:27Z","timestamp":1764330807944},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,11,24]],"date-time":"2010-11-24T00:00:00Z","timestamp":1290556800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Herzschr. Elektrophys."],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s00399-010-0091-0","type":"journal-article","created":{"date-parts":[[2010,11,22]],"date-time":"2010-11-22T05:02:58Z","timestamp":1290402178000},"page":"239-243","source":"Crossref","is-referenced-by-count":9,"title":["Aktueller Stellenwert von Amiodaron in der antiarrhythmischen Therapie"],"prefix":"10.1007","volume":"21","author":[{"given":"C.","family":"Sohns","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Zabel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,11,24]]},"reference":[{"key":"91_CR1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","volume":"352","author":"Bardy","year":"2005","unstructured":"Bardy GH, Lee KL, Mark DB et al (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352:225\u2013237","journal-title":"N Engl J Med"},{"key":"91_CR2","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.amjmed.2004.11.028","volume":"118","author":"Basaria","year":"2005","unstructured":"Basaria S, Cooper DS (2005) Amiodarone and the thyroid. Am J Med 118:706\u2013714","journal-title":"Am J Med"},{"key":"91_CR3","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/0002-9149(91)90895-R","volume":"67","author":"CASCADE","year":"1991","unstructured":"CASCADE Investigators (1991) Cardiac arrest in Seattle: conventional versus amiodarone drug evaluation. Am J Cardiol 67:578\u2013584","journal-title":"Am J Cardiol"},{"key":"91_CR4","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1056\/NEJM198908103210629","volume":"321","author":"CAST","year":"1989","unstructured":"CAST Investigators The Cardiac Arrhythmia Suppression Trial (1989) Effect of encainide and flecainide on mortality in infarction. N Engl J Med 321:406\u2013412","journal-title":"N Engl J Med"},{"key":"91_CR5","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1161\/01.CIR.100.19.2025","volume":"100","author":"Connolly","year":"1999","unstructured":"Connolly SJ (1999) Evidence-based analysis of amiodarone efficacy and safety. Circulation 100:2025\u20132034","journal-title":"Circulation"},{"key":"91_CR6","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1056\/NEJMoa013029","volume":"346","author":"Dorian","year":"2002","unstructured":"Dorian P, Cass D, Cooper R et al (2002) Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation. N Engl J Med 346:884\u2013890","journal-title":"N Engl J Med"},{"key":"91_CR7","doi-asserted-by":"crossref","first-page":"95F","DOI":"10.1016\/0002-9149(93)90970-N","volume":"72","author":"EMIAT","year":"1993","unstructured":"EMIAT Investigators, Camm AJ, Julian D, Janse G et al (1993) The European Myocardial Infarct Amiodarone Trial (EMIAT). Am J Cardiol 72(16):95F\u201398F","journal-title":"Am J Cardiol"},{"key":"91_CR8","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-121-7-199410010-00009","volume":"121","author":"Hohnloser","year":"1994","unstructured":"Hohnloser SH, Klingenheben T, Singh BN (1994) Amiodarone-associated proarrhythmic effects. A review with special reference to torsade de pointes tachycardia. Ann Intern Med 121(7):529\u2013535","journal-title":"Ann Intern Med"},{"key":"91_CR9","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.pcad.2007.12.001","volume":"50","author":"Kamath","year":"2008","unstructured":"Kamath GS, Mittal S (2008) The role of antiarrhythmic drug therapy for the prevention of sudden cardiac death. Prog Cardiovasc Dis 50:439\u2013448","journal-title":"Prog Cardiovasc Dis"},{"key":"91_CR10","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/j.1540-8167.2005.50006.x","volume":"16","author":"Kies","year":"2005","unstructured":"Kies P, Boersma E, Bax JJ et al (2005) Determinants of recurrent ventricular arrhythmia or death in 300 consecutive patients with ischemic heart disease who experienced aborted sudden death: data from the Leiden out-of-hospital cardiac arrest study. J Cardiovasc Electrophysiol 16:1049\u20131056","journal-title":"J Cardiovasc Electrophysiol"},{"key":"91_CR11","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1056\/NEJM199909163411203","volume":"341","author":"Kudenchuk","year":"1999","unstructured":"Kudenchuk PJ, Cobb LA, Copass MK (1999) Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. N Engl J Med 341:871\u2013878","journal-title":"N Engl J Med"},{"key":"91_CR12","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1540-8167.2010.01764.x","volume":"21","author":"Le","year":"2010","unstructured":"Le Heuzey JY, De Ferrari GM, Radzik D et al (2010) A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study. J Cardiovasc Electrophysiol 21:597\u2013605","journal-title":"J Cardiovasc Electrophysiol"},{"key":"91_CR13","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/0002-9149(94)90463-4","volume":"74","author":"Man","year":"1994","unstructured":"Man KC, Williamson BD, Niebauer M et al (1994) Electrophysiologic effects of sotalol and amiodarone in patients with sustained monomorphic ventricular tachycardia. Am J Cardiol 74:1119\u20131123","journal-title":"Am J Cardiol"},{"key":"91_CR14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.295.2.165","volume":"295","author":"OPTIC","year":"2006","unstructured":"OPTIC Investigators. Connolly SJ, Dorian P, Roberts RS et al (2006) Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial. JAMA 295:165\u2013171","journal-title":"JAMA"},{"key":"91_CR15","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1378\/chest.123.2.646","volume":"123","author":"Ott","year":"2003","unstructured":"Ott MC, Khoor A, Leventhal JP et al (2003) Pulmonary toxicity in patients receiving low-dose amiodarone. Chest 123(2):646\u2013651","journal-title":"Chest"},{"key":"91_CR16","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJM200003303421302","volume":"342","author":"Roy","year":"2000","unstructured":"Roy D, Talajic M, Dorian P et al (2000) Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. N Engl J Med 342:913\u2013920","journal-title":"N Engl J Med"},{"key":"91_CR17","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1056\/NEJMoa041705","volume":"352","author":"Singh","year":"2005","unstructured":"Singh BN, Singh SN, Reda DJ et al (2005) Amiodarone versus sotalol for atrial fibrillation. N Engl J Med 352:1861\u20131872","journal-title":"N Engl J Med"},{"key":"91_CR18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM199507133330201","volume":"333","author":"Singh","year":"1995","unstructured":"Singh SN, Fletcher RD, Fisher SG et al (1995) Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. N Engl J Med 333:77\u201382","journal-title":"N Engl J Med"},{"key":"91_CR19","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1136\/hrt.2008.152652","volume":"96","author":"van","year":"2010","unstructured":"van Erven L, Schalij MJ (2010) Amiodarone: an effective antiarrhythmic drug with unusual side effects. Heart 96:1593\u2013600","journal-title":"Heart"},{"key":"91_CR20","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa021375","volume":"347","author":"van","year":"2002","unstructured":"van Gelder ICD, Hagens VE, Bosker HA et al (2002) A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 347:1834\u20131840","journal-title":"N Engl J Med"},{"key":"91_CR21","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1001\/jama.298.11.1312","volume":"298","author":"Vassallo","year":"2007","unstructured":"Vassallo P, Trohman RG (2007) Prescribing amiodarone: an evidence-based review of clinical indications. JAMA 298:1312\u20131322","journal-title":"JAMA"},{"key":"91_CR22","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0735-1097(97)00220-9","volume":"30","author":"Vorperian","year":"1997","unstructured":"Vorperian VR, Havighurst TC, Miller S, January CT (1997) Adverse effects of low dose amiodarone: a meta-analysis. J Am Coll Cardiol 30:791\u2013798","journal-title":"J Am Coll Cardiol"},{"key":"91_CR23","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s10557-009-6189-0","volume":"23","author":"Yalta","year":"2009","unstructured":"Yalta K, Turgut O, Yilmaz M et al (2009) Dronedarone: a promising alternative for the management of atrial fibrillation. Cardiovasc Drugs Ther 23:385\u2013393","journal-title":"Cardiovasc Drugs Ther"},{"key":"91_CR24","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jacc.2006.04.072","volume":"48","author":"Ypenburg","year":"2006","unstructured":"Ypenburg C, Erven L van, Bleeker GB et al (2006) Benefit of combined resynchronization and defibrillator therapy in heart failure patients with and without ventricular arrhythmias. J Am Coll Cardiol 48:464\u2013470","journal-title":"J Am Coll Cardiol"}],"container-title":["Herzschrittmachertherapie + Elektrophysiologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00399-010-0091-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00399-010-0091-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00399-010-0091-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T13:16:43Z","timestamp":1559049403000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00399-010-0091-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,24]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["91"],"URL":"https:\/\/doi.org\/10.1007\/s00399-010-0091-0","relation":{},"ISSN":["0938-7412","1435-1544"],"issn-type":[{"value":"0938-7412","type":"print"},{"value":"1435-1544","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,24]]}}}